Not applicableWithdrawnNCT02306512What this trial is testingMohs and Immunofluorescence for Malignant Melanoma In SituWho this might be right forLentigo MalignaMelanoma In Situ University of Miami
Not applicableEnrolling By InvitationNCT06388252What this trial is testingElectrochemotherapy Induces Changes in the Tumor Microenvironment of Cutaneous and Subcutaneous Metastases in Patients With Cutaneous MelanomaWho this might be right forCutaneous Malignant Melanoma Institute of Oncology Ljubljana 10
Early research (Phase 1)Ended earlyNCT00492440What this trial is testingInterleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney CancerWho this might be right forKidney CancerMelanoma (Skin) Cytheris SA 9
Testing effectiveness (Phase 2)Study completedNCT00334776What this trial is testingVaccine Therapy in Treating Patients With Metastatic MelanomaWho this might be right forIntraocular MelanomaMelanoma (Skin) University of Southern California 6
Not applicableLooking for participantsNCT06887348What this trial is testingAssess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3Who this might be right forMelanomaMetastatic MelanomaAdvanced Solid Tumor+1 more Replimune Inc. 50
Not applicableStudy completedNCT02902822What this trial is testingTele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of BergamoWho this might be right forErysipelasImpetigoHerpes Zoster+7 more Centro Studi Gised 461
Not applicableEnded earlyNCT04688749What this trial is testingUse of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin DamageWho this might be right forMelanoma (Skin)Basal Cell CarcinomaSquamous Cell Carcinoma+5 more Aristotle University Of Thessaloniki 50
Testing effectiveness (Phase 2)Study completedNCT00004135What this trial is testingChemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney CancerWho this might be right forKidney CancerMelanoma (Skin) University of Chicago 19
Early research (Phase 1)Study completedNCT01522820What this trial is testingVaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsWho this might be right forAnaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more Roswell Park Cancer Institute 18
Not applicableStudy completedNCT01886235What this trial is testingIntravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by SurgeryWho this might be right forRecurrent MelanomaStage IA Skin MelanomaStage IB Skin Melanoma+7 more Roswell Park Cancer Institute 10
Early research (Phase 1)Active Not RecruitingNCT05492682What this trial is testingSTART: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of CancerWho this might be right forMelanoma (Skin)Triple-Negative Breast CancerNon-Small Cell Lung Cancer+5 more Valo Therapeutics Oy 15
Not applicableLooking for participantsNCT03906253What this trial is testingEffectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic NeoplasiaWho this might be right forActinic KeratosesAgingNon-Melanoma Skin Cancer Wright State University 72
Large-scale testing (Phase 3)Active Not RecruitingNCT06320353What this trial is testingStudy сomparing the Efficacy and Safety of RPH-075 and Keytruda® in Patients With Unresectable or Metastatic Skin MelanomaWho this might be right forSkin Melanoma R-Pharm 266
Testing effectiveness (Phase 2)Study completedNCT00062036What this trial is testingCyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic MelanomaWho this might be right forMelanoma (Skin) National Institutes of Health Clinical Center (CC) 33
Not applicableStudy completedNCT03094273What this trial is testingProspective Study of 2 mm Margins for the Biopsy of Dysplastic NeviWho this might be right forDysplastic Nevi NYU Langone Health 138
Very early researchStudy completedNCT02320305What this trial is testingMART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by SurgeryWho this might be right forStage IIA Skin MelanomaStage IIB Skin MelanomaStage IIC Skin Melanoma+4 more Mayo Clinic 23
Not applicableStudy completedNCT04911998What this trial is testingA Prospective Observational Study on Targeted Therapy for Unresectable or Metastatic BRAFV600E Mutant Melanoma PatientsWho this might be right forMelanoma (Skin)Metastatic MelanomaBRAF V600 Mutation Pierre Fabre Medicament 400
Early research (Phase 1)Study completedNCT02318771What this trial is testingRadiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung CancerWho this might be right forHead and Neck Squamous Cell CarcinomaMetastatic Renal Cell CancerRecurrent Head and Neck Carcinoma+6 more Sidney Kimmel Cancer Center at Thomas Jefferson University 41
Testing effectiveness (Phase 2)Ended earlyNCT00704938What this trial is testingGene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic CancerWho this might be right forKidney CancerMelanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific National Institutes of Health Clinical Center (CC) 3
Early research (Phase 1)Looking for participantsNCT06377111What this trial is testingTest the Benefit of Vitamin B5 in Patients With MelanomaWho this might be right forMelanoma (Skin) University Health Network, Toronto 12